STAT+: Gilead sues Russia over a compulsory license issued to a company making remdesivir



Amid worldwide clamoring for Covid-19 vaccines and other therapies, Gilead Sciences (GILD) last month filed a lawsuit against the Russian government for allowing a domestic company to manufacture and market its remdesivir treatment, which is also known as Veklury.

The move came after the government late last year issued a compulsory license to a company called Pharmasyntez, which unsuccessfully approached Gilead about obtaining a license to produce a version of the medicine. At the time, the health minister pursued the step “in the interest of national security,” and the company indicated plans to sell its version about half the cost.

Continue to STAT+ to read the full story…

Source link

Comments are closed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy